70 related articles for article (PubMed ID: 2420674)
1. [Evaluation of the antiviral and cellular antireplication effect of human interferon on a line of primary hepatocarcinoma].
Clementi M; Bagnarelli P; Frezza G; Santirocco N; Manzin A; Brugia M; Calegari L
G Ital Chemioter; 1985; 32(1):137-40. PubMed ID: 2420674
[No Abstract] [Full Text] [Related]
2. Effect of human leukocyte interferon on HBsAg production in PLC/PRF/5 human hepatoma cell line.
Hajnická V; Stancek D
Acta Virol; 1987 Sep; 31(5):404-9. PubMed ID: 2891279
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line.
Manzin A; Bagnarelli P; Brugia M; Pauri P; Clementi M
Ric Clin Lab; 1986; 16(3):457-62. PubMed ID: 2433727
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenicity and interferon properties of the PLC/PRF/5 human hepatoma cell line.
Desmyter J; De Groote G; Ray MB; Bradburne AF; Desmet V; De Somer P; Alexander J
Prog Med Virol; 1981; 27():103-8. PubMed ID: 6165050
[No Abstract] [Full Text] [Related]
5. [Primary hepatocarcinoma and hepatitis B virus in Sardinia].
Lai ME; Faa G; Farci P; Liguori C; Figus A; Costa V; Balestrieri A
Pathologica; 1988; 80(1068):443-8. PubMed ID: 2854232
[No Abstract] [Full Text] [Related]
6. A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression.
Bagnarelli P; Brugia M; Clementi M
Dev Biol Stand; 1985; 60():45-53. PubMed ID: 2995177
[TBL] [Abstract][Full Text] [Related]
7. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.
Hajnická V; Fuchsberger N; Liptáková H; Stancek D; Kontsek P
Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant.
Lai MW; Yeh CT
Antivir Ther; 2008; 13(7):875-9. PubMed ID: 19043921
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
[TBL] [Abstract][Full Text] [Related]
10. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
Yamashita Y; Koike K; Takaoki M; Matsuda S
Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.
Xiong W; Wang X; Liu XY; Xiang L; Zheng LJ; Liu JX; Yuan ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494
[TBL] [Abstract][Full Text] [Related]
12. [Adaptation to defined chemical conditions of the in vitro growth of PLC/PRF/5 cells].
Bagnarelli P; Festa A; Testa I; Manzin A; Clementi M
Boll Soc Ital Biol Sper; 1985 Oct; 61(10):1513-20. PubMed ID: 3006729
[No Abstract] [Full Text] [Related]
13. Prevention of hepatocellular carcinoma by immunization against hepatitis B.
Zuckerman AJ
Int Rev Exp Pathol; 1985; 27():59-81. PubMed ID: 3017884
[No Abstract] [Full Text] [Related]
14. Hepatitis B virus DNA and human hepatocellular carcinoma.
Brechot C; Wain-Hobson S; Pourcel C; Dejean A; Hadchouel M; Scotto J; Tiollais P
Prog Clin Biol Res; 1983; 132D():495-504. PubMed ID: 6314366
[No Abstract] [Full Text] [Related]
15. Pathobiology of hepatitis B virus.
Gerber MA; Thung SN
Pathobiol Annu; 1981; 11():197-228. PubMed ID: 6276845
[No Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma cell line and peripheral blood lymphocytes from the same patient contain common chromosomal alterations.
Simon D; Knowles BB
Lab Invest; 1986 Dec; 55(6):657-65. PubMed ID: 3023751
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5).
Berthillon P; Crance JM; Leveque F; Jouan A; Petit MA; Deloince R; Trepo C
J Hepatol; 1996 Jul; 25(1):15-9. PubMed ID: 8836896
[TBL] [Abstract][Full Text] [Related]
18. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
19. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus, HLA types and interferon.
Vladutiu AO
N Engl J Med; 1977 Aug; 297(7):399. PubMed ID: 876337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
